S. Sasaki et al., The search for a potent DNA vaccine against AIDS: The enhancement of immunogenicity by chemical and genetic adjuvants, ANTICANC R, 18(5D), 1998, pp. 3907-3915
DNA vaccination is a new way to generate antigen specific immune responses
by inoculating plasmid DNA encoding microbial genes. We believe that the us
e of immunologic adjuvants together with DNA vaccines is a promising way to
enhance and optimize DNA-derived immunity. Various chemical and genetic ad
juvants have been explored in our recent study. Data from these studies sug
gests that adjuvants exert their immunomodulatory properties through severa
l mechanisms such as lymphoid cells recruitment, cytokine induction, and th
e facilitation of DNA entry into cells. Furthermore, each adjuvant has uniq
ue immunomodulatory effects on cell-mediated and humoral immune responses i
nduced by DNA vaccination to human immunodeficiency virus type 1. To optimi
ze the desirable immune response, the choice of adjuvant and decision of im
munization route are important considerations. A similar approach may be us
eful potentiating anticancer immunotherapy as well.